ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $55,282,000 | -33.7% | 1,193,224 | -65.1% | 6.04% | -35.3% |
| Q1 2019 | $83,393,000 | +23.4% | 3,420,562 | -27.9% | 9.34% | +5.7% |
| Q4 2018 | $67,603,000 | -29.3% | 4,744,062 | -24.6% | 8.84% | +5.2% |
| Q3 2018 | $95,617,000 | +22.0% | 6,290,586 | +34.6% | 8.40% | +9.8% |
| Q2 2018 | $78,399,000 | -5.1% | 4,672,195 | -7.7% | 7.65% | -8.6% |
| Q1 2018 | $82,624,000 | -25.7% | 5,062,768 | -41.7% | 8.38% | -37.5% |
| Q4 2017 | $111,187,000 | +41.2% | 8,686,498 | +35.7% | 13.40% | +33.9% |
| Q3 2017 | $78,751,000 | +55.3% | 6,402,525 | +5.7% | 10.01% | +27.1% |
| Q2 2017 | $50,719,000 | +105.3% | 6,059,625 | +119.3% | 7.88% | +87.5% |
| Q1 2017 | $24,702,000 | -43.6% | 2,763,086 | -44.6% | 4.20% | -52.3% |
| Q4 2016 | $43,829,000 | +0.5% | 4,986,186 | -22.8% | 8.81% | +7.2% |
| Q3 2016 | $43,613,000 | +48.3% | 6,461,186 | -21.8% | 8.22% | +31.2% |
| Q2 2016 | $29,409,000 | +27.0% | 8,260,897 | +5.2% | 6.26% | +9.3% |
| Q1 2016 | $23,158,000 | -17.9% | 7,850,211 | +17.5% | 5.73% | +19.2% |
| Q4 2015 | $28,201,000 | -36.1% | 6,682,711 | -31.0% | 4.81% | -46.1% |
| Q3 2015 | $44,144,000 | -33.2% | 9,680,630 | +5.6% | 8.92% | -23.6% |
| Q2 2015 | $66,110,000 | -4.6% | 9,169,276 | -2.5% | 11.67% | -19.5% |
| Q1 2015 | $69,321,000 | +24.5% | 9,405,817 | -20.1% | 14.50% | +33.8% |
| Q4 2014 | $55,683,000 | +12.4% | 11,772,335 | -15.2% | 10.83% | +5.3% |
| Q3 2014 | $49,539,000 | -26.2% | 13,876,513 | -5.7% | 10.29% | -3.1% |
| Q2 2014 | $67,104,000 | +68.2% | 14,715,786 | +73.4% | 10.61% | +71.6% |
| Q1 2014 | $39,889,000 | +5.4% | 8,486,927 | +12.4% | 6.18% | -6.6% |
| Q4 2013 | $37,841,000 | -37.4% | 7,553,089 | -22.3% | 6.62% | -36.4% |
| Q3 2013 | $60,456,000 | +19.6% | 9,719,589 | -12.7% | 10.40% | +6.1% |
| Q2 2013 | $50,539,000 | – | 11,131,858 | – | 9.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |